The short answer
Free Light Chain Ratio is a report or oncology term that needs context from the full diagnosis, test method, symptoms, and treatment goal.
What Does Free Light Chain Ratio Mean? is a planning topic, not a diagnosis or treatment instruction by itself.
The next step depends on diagnosis, symptoms, goals, prior results, and what is still pending.
Use the page to prepare specific questions for a clinician who can review the full record.
Choose how you want to understand this
The full explanation.
Two shapes of one spare part
An antibody is built from heavy chains and light chains. MedlinePlus explains that light chains are "proteins made by plasma cells, a type of white blood cell." Plasma cells make extra light chains beyond what the antibodies need. The leftovers float loose in the blood. Those are free light chains.
Light chains come in exactly two shapes: kappa and lambda. MedlinePlus notes that "you will usually have some of each in your blood." The test "measures the amount of lambda and kappa free light chains in your blood."
Healthy plasma cells are a crowd of many different cells. That crowd makes both shapes in a fairly steady mix. A cancerous plasma cell clone comes from one single cell, so it makes only one shape. That is the whole idea behind the ratio. It looks for a crowd that has stopped being a crowd.
Reading your own report line
Your result usually has three numbers. A kappa level, a lambda level, and the kappa/lambda ratio.
Oncology notes use two other words. The involved light chain is the one the clone is overproducing. The uninvolved one is the other. In kappa-driven disease, kappa is involved and lambda is uninvolved. Guidelines are written as involved over uninvolved. That way one rule covers both directions.
Reference ranges are printed next to the result. They belong to the exact assay that lab runs. Do not compare a ratio from one hospital against a range printed by another. If you switch labs during treatment, tell your oncologist. The trend line can jump for reasons that have nothing to do with your disease.
The kidney problem
The kidneys clear free light chains from the blood. So kidney function changes the levels. MedlinePlus notes that "kidney conditions" can raise free light chains with no plasma cell disease present.
That is why a mildly odd ratio in someone with chronic kidney disease often means little. It is also why your team checks creatinine on the same day. And it is why a wildly abnormal ratio plus a rising creatinine gets treated as urgent. Light chains can clog and injure the tiny tubes inside the kidney.
The number that changes a diagnosis: 100
One threshold does real work here. The National Cancer Institute lists an "involved:uninvolved serum FLC ratio of 100 or more" as a myeloma-defining event. StatPearls, the peer-reviewed reference on the NIH National Library of Medicine Bookshelf, states the same rule.
It belongs to a checklist called SLiM CRAB. That checklist separates active multiple myeloma from earlier stages. The SLiM half covers three findings that predict fast progression, even with no symptoms:
- S — clonal bone marrow plasma cells of 60% or more
- Li — involved/uninvolved free light chain ratio of 100 or more
- M — MRI showing more than one focal lesion, each larger than 5 mm
The CRAB half covers organ damage that is already happening. StatPearls gives four values. Calcium above 11 mg/dL, which is 2.75 mmol/L. Creatinine above 2 mg/dL. Hemoglobin below 10 g/dL. And lytic bone lesions, meaning holes in bone, on imaging.
NCI words the same four slightly differently. Calcium more than 1 mg/dL above the lab's own range. Creatinine above 2 mg/dL, or creatinine clearance below 40 mL/min. Hemoglobin below 10.0 g/dL. One or more bone lesions on x-ray, CT, PET-CT, or MRI.
Any single item on either half is enough. That is why one ratio can move a person from watchful waiting to treatment.
Why the same number means less in smoldering disease
NCI defines smoldering myeloma by three things. Serum monoclonal protein of at least 30 g/L, of the IgG or IgA type. Clonal bone marrow plasma cells between 10% and 60%. And no myeloma-defining events.
Monoclonal gammopathy of undetermined significance, or MGUS, sits below that. NCI describes an M protein in the serum with no sign of myeloma, macroglobulinemia, amyloidosis, or lymphoma. Marrow plasma cells stay under 10%.
Inside smoldering disease, the ratio acts as a risk dial rather than a switch. NCI reports that a "FLC ratio of over 100 can predict a greater than 70% progression within 2 years in patients with smoldering myeloma." That one statistic explains a lot. Two people with the same label can be handed very different follow-up schedules.
Why this test replaced a jug of urine
The old way to find loose light chains was a 24-hour urine collection. It looked for Bence-Jones protein. StatPearls describes that protein as an immunoglobulin light chain with no heavy chain attached. It weighs about 22,000 daltons. It was first identified by a heat trick: the urine clouds over between 40°C and 60°C, then clears again at 100°C.
Two practical facts follow. First, StatPearls notes that Bence-Jones protein "is undetectable by dipsticks used to detect proteinuria since they detect albumin." A normal urine dipstick does not rule this out. Second, StatPearls reports that the International Myeloma Working Group "now suggests using serum free light chain (sFLC) assay instead of urine protein electrophoresis and immunofixation electrophoresis if multiple myeloma is suspected." A blood draw beat the jug.
The blood assay also responds fast. Free light chains have a very short half-life in the body. That makes the ratio an early signal of whether treatment is working.
What it gets read alongside
StatPearls lists the standard panel. Serum protein electrophoresis, or SPEP. Serum immunofixation electrophoresis, or SIFE. Then the urine versions, UPEP and UIFE. These tests prove clonality. They show that one light chain type has taken over.
StatPearls reports that pairing serum protein electrophoresis with the free light chain assay "will diagnose 100% of cases of multiple myeloma."
Immunofixation still earns its place. StatPearls notes it "is still required to detect amyloidosis." In that disease, light chains, often lambda, misfold and pile up in the heart, kidneys, nerves, or gut. MedlinePlus also lists Waldenstrom macroglobulinemia among the conditions this test helps sort out.
Questions worth asking about your result
Which chain is involved, kappa or lambda? What is my exact ratio, and what range does this lab use? Was my creatinine drawn the same day? Could kidney function explain part of this? Am I above or below a ratio of 100, and does that change my category? Is a bone marrow biopsy, an immunofixation, or a bone survey still pending? How often will this be repeated? How big a change counts as real?
Related pages
See also Pathology Reports, Cancer Staging, and Biomarker Testing and Precision Medicine.
Sources
Words to know
Tap any term to see what it means.
Common questions
Does this page tell me what treatment to choose?
No. It explains the topic in plain language so you can ask better questions. Your care team applies it to your diagnosis, test results, and goals.
What should I bring to the visit?
Bring the report, medicine list, recent test results, and a written list of questions. Ask what result or decision is still pending.
When is this more urgent?
Use the urgent instructions from your care team for severe, fast-changing, or treatment-specific warning symptoms.
Questions to ask your doctor
Being prepared helps you get the most out of your appointments. Save or print these questions.
Tap a question to save it to your list (kept on this device).
Your next step
Turn this topic into questions for your next appointment.
Speak With Trained Specialists & Human Navigators
Cancer Explained provides educational guidance, but does not replace trained specialists, social workers, or your medical team.
Talk to a trained cancer information specialist
Free, confidential assistance from NCI Cancer Information Service via phone, chat, or email.
Contact your oncology team
Locate after-hours contact numbers, portal messages, or urgent triage phone lines.
Find a patient navigator
Get one-on-one help with appointments, logistics, translation, and care coordination.
Find a genetic counselor
Discuss inherited mutation risk, family history, and genetic testing options.
Find an oncology social worker
Access emotional counseling, family support groups, and mental health resources.
Find a financial navigator
Locate copay assistance foundations, grant programs, and lodging/travel support.
Find a clinical-trial specialist
Search matching studies and speak with NCI trial information specialists.
Get urgent help
Immediate emergency guidance for fever (>100.4°F during chemo), severe pain, or shortness of breath.
Help Us Improve This Guide
Did this explanation answer your question and help you determine your next step?
Know someone who needs this?
Plenty of people are looking for something like this and do not know where to start. If this would help a friend or someone you love, send it on — we have written an opening line so you do not have to stare at an empty message. You can change every word of it.
Your message is written and sent in your own email or messaging app — we never see who you send it to, and nothing is added to any list.
Plain-language explanation of the published sources cited on this page. AI-assisted, source-checked, not clinician-reviewed.
Sources last checked: 2026-07-21 what this meansLast updated: 2026-08-13Next planned review: 2027-07-21
How this page was created
Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes. We do not employ clinicians and do not intend to — our work is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.
Editorial status — Source checked. This page was written with AI assistance and checked line by line against the sources listed on it. That confirms the sources support what the page says. It is not a medical review, and it does not confirm the page is complete or right for your situation.
General education — varies by person. Answers genuinely differ between people. This page explains what commonly varies and points you to your care team for your situation.
Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.
How this page was created
Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes. We do not employ clinicians and do not intend to — our work is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.
Editorial status: Source checked — This page was written with AI assistance and checked line by line against the sources listed on it. That confirms the sources support what the page says. It is not a medical review, and it does not confirm the page is complete or right for your situation.
Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.
Read more about our editorial process, our use of AI, and our corrections policy.
Spotted a problem? Report an error — a factual mistake, broken or outdated source, confusing wording, or anything that seems unsafe. Please do not include names, medical record numbers, dates of birth, addresses, or other identifying medical information in your report.
After using this page, do you understand what to do next?
Anonymous — we only record the answer, never who gave it.
Related articles
Still have questions?
Educational answers, plain language
Free to print and share